Health Products

APO-Fluoxetine (2015-04-17)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
Bottle of 100 Capsules:
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
A. APO-FluoxetineCapsuleDIN 02216361Fluoxetine (Fluoxetine hydrochloride) 20 mg

Introduction

Recalled products
  1. APO-Fluoxetine

Reason

The active pharmaceutical ingredient (API) used in the manufacturing of these lots may not meet the specification for impurity - isobutyl vinyl ketone (IBVK)

Depth of distribution

Retailers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime